Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer.

Saved in:
Bibliographic Details
Title: Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer.
Authors: Cavalcanti-Neto MP; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA; Institute of Biodiversity and Sustainability of Macaé, Federal University of Rio de Janeiro, Macaé, Rio de Janeiro, Brazil., Brauer VS; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Rella A; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Shamseddine A; Department of Medicine, Stony Brook University, Stony Brook, New York, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA., Dasilva D; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Matos GS; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., de Sa NP; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA., Shroyer K; Department of Pathology, Stony Brook University, Stony Brook, New York, USA., Hannun Y; Department of Medicine, Stony Brook University, Stony Brook, New York, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, USA., Del Poeta M; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA; Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, USA; United States Department of Veterans Affairs, VA Medical Center, Northport, NY, USA. Electronic address: maurizio.delpoeta@stonybrook.edu.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 Aug; Vol. 201, pp. 119653. Date of Electronic Publication: 2026 Jun 12.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1950-6007
DOI:10.1016/j.biopha.2026.119653